KI-3106 is under clinical development by Kuhnil Pharmaceutical and currently in Phase I for Hyperlipidemia. According to GlobalData, Phase I drugs for Hyperlipidemia have a 72% phase transition ...

Searching for effective treatment options for 'High Cholesterol symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

Other factors that may complicate treatment of hyperlipidemia include metabolism of many antiretroviral drugs by the cytochrome P-450 isoenzyme system, polypharmacy, and drug-food interactions.

The Global Metabolism Drugs Market, valued at approximately USD 16.10 billion in 2022, is projected to grow at a robust CAGR of more than 6.50% during the forecast period from 2023 to 2030. Metabolism ...